AzTrials
AzTrials

RecoveryNCT06815640

Effects of Intermittent Pneumatic Compression on Recovery of Cyclists

A study testing recovery in people with Recovery, run by University of Maia at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to assess the recovery kinetics of road cyclists following a fatigue protocol (30 time trial). Read more about this study

Who is it for?
Ages 18 to 35 years, men onlyHealthy volunteers can take part
Conditions the study is for
Recovery
What is being tested?
recovery
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
21 participants
Where
1 sitePortugal
Study dates
15 Feb 2025to 12 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Road cyclists competing nationally

Who cannot join

  • Injured athletes

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Universidade da Maia

    Maia

Other trials in Portugal

About this study

Official title: Effects of Intermittent Pneumatic Compression on the Recovery of High-level Cyclists

This study aims to assess the recovery kinetics of road cyclists following a fatigue protocol (30 time trial).

Conditions
Recovery
Being tested
recovery
Keywords
sports, compression, recovery, cycling

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • recoveryOther

    Fatigue protocol

Study groups in NCT06815640
Study groupRoleWhat they receive
IPCExperimentalIntermittent pneumatic compression treatment (30 min peristaltic protocol, at 200mmHg)
Receives: Other: recovery
PlaceboPlacebo comparatorA hydrant cream will be used as a placebo
Receives: Other: recovery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle soreness

    Muscle soreness will be assessed using the likert scale of muscle soreness (ranging from 0 to 6)

    Measured: Baseline, post 30 minutes, post 24 hours, and post 48 hours

  2. Creatine Kinase

    Creatine kinase will be assessed

    Measured: Baseline, post 30 minutes, post 24 hours, and post 48 hours

Secondary outcomes (7)
  1. Low frequency fatigue - Myocece Powerdex score

    Low frequency fatigue will be assessed using Myocene

    Measured: Baseline, post 30 minutes, post 24 hours, and post 48 hours

  2. 4 min time trial

    A 4 minute time trial will be conducted at the 24th hour post-intervention.

    Measured: 24 hours post intervention

  3. Isometric knee extension srength

    Isometric Knee extension exercise will be assessed

    Measured: Baseline, post 30 minutes, post 24 hours, and post 48 hours

  4. Percieved fatigue

    Likert scale of percieved fatigue (ranging from 0 to 10)

    Measured: Baseline, post 30 minutes, post 24 hours, and post 48 hours

  5. Sleep questionnaires (consensus sleep diary)

    Sleep quality and quantity will be assessed using a questionnaire, based on the consensus sleep diary

    Measured: Baseline, post 30 minutes, post 24 hours, and post 48 hours

  6. Perceived recovery

    Total quality recovery scale will be used

    Measured: Baseline, post 30 minutes, post 24 hours, and post 48 hours

  7. Nutritional diaries

    Participants will be asked about their nutritional intake during the timecourse of the assessments

    Measured: Baseline, post 24 hours, and post 48 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Feb 2025
  2. Study start15 Feb 2025
  3. Primary completion15 Apr 2025
  4. Study completion12 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06815640
Sponsor's protocol ID
PDFM_005
Status last verified
Jul 2025
First submitted
12 Jan 2025
Last updated
30 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing recovery in people with Recovery, run by University of Maia at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle soreness (time frame: Baseline, post 30 minutes, post 24 hours, and post 48 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in